Product
AI AGENTS
INTELLIGENCE SUITE
API, MCP & INTEGRATION
Solutions
INDUSTRIES
USE CASES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
Patsnap Eureka Platform
IP Search Agents
IP Drafting Agents
Engineering Agents
Find Solutions with TRIZ
Life Sciences Agents
Materials Agents
SEP Agents
Patsnap Eureka Desktop
BetaAnalytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisProfessional Services
Open Platform
Developer Center
Customer Stories
Newsroom
Blog
Global Innovation Report
Glossary
Webinars & Training
User Community
R&D Benchmark Calculator
Trust and Security
PatentBench
NEWLLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Unlock professional features and history
Already have an account? Log In
To start using Patsnap Eureka, click the verification button in the email we sent to .
This helps keep your account secure.
Haven't received it? Check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report A 2026 patent landscape of hydrothermal liquefaction (HTL) technology: reactor design, feedstock trends, key assignees, and emerging IP white spaces.
Article | Report How does RLHF differ from DPO in LLM fine-tuning? A patent-backed technical comparison of architectures, tradeoffs, and hybrid approaches across 60+ filings.
Article | Report How light-sensitive opsins are reshaping drug discovery in 2026: from AAV gene therapy for blindness to in vivo neuronal screening platforms and GPCR target validation tools.
Article | Report How to achieve sub-10 millisecond thermal runaway detection in battery management systems: hardware circuits, hierarchical architectures, EIS, and multi-sensor fusion strategies.
Article | Report Beta-3 agonists, muscarinic antagonists, and BTX combination approaches are reshaping the OAB drug pipeline. Explore the patent landscape and emerging targets.
Article | Report A 2026 patent landscape analysis of microwave energy harvesting: rectenna systems, IRS-assisted WPT, SWIPT beamforming, and ambient RF harvesting across IoT, 5G, and aerospace.
Article | Report Electrochemical ammonia synthesis (eNRR) is reshaping green chemistry. Explore the 2026 patent landscape: catalysts, plasma hybrids, NOₓ routes, and geographic IP trends.
Article | Report How active cell balancing topologies recover usable capacity in high-voltage EV battery packs — circuit architectures, hierarchical control, and key patent trends.
Article | Report How active cell balancing topologies recover usable capacity in high-voltage EV battery packs — circuit architectures, hierarchical control, and key patent trends.
Article | Report A deep-dive into the 2026 TENG patent landscape: key assignees, material advances, power management IP, hybrid devices, and emerging application domains.
Article | Report Oral GnRH antagonists, SPRMs, and non-surgical approaches are reshaping the uterine fibroids drug pipeline. Explore patent signals, key compounds, and strategic IP trends.
Article | Report A 2026 patent landscape analysis of triboelectric nanogenerator (TENG) technology: key assignees, material advances, power management IP, and emerging application domains.
Article | Report How do ToF and FMCW LiDAR signal processing differ for autonomous vehicles? A patent intelligence analysis of 60+ filings from Waymo, Aurora, Baidu & more.
Article | Report Mapping the 2026 patent landscape for underwater acoustic communication: hybrid acoustic-optical systems, AI-driven mode selection, AUV swarms, and emerging IP white spaces.
Article | Report Explore the NIU drug pipeline: suprachoroidal steroid delivery, anti-IL-6R biologics, IL-1β inhibitors, and gene therapy approaches shaping uveitis treatment.